Document is current
Any future updates will be listed below
-
Authors
Planchak, Sarah https://orcid.org/0009-0005-0135-4542
Welch, E. Celeste https://orcid.org/0000-0003-0691-1449
Phelps, Benjamin
Phelps, Joshua
Hernandez Moyers, Alejandra
Whitehead, Kathryn https://orcid.org/0009-0001-1635-946X
Murphy, John
Tapinos, Nikos https://orcid.org/0000-0002-3798-5363
Tripathi, Anubhav https://orcid.org/0000-0002-8915-2320
-
Funding
Funding for this research was provided by:
Revvity (Revvity1)
Brown Biomedical Innovations to Impact (BBII1)
Brown Graduate Fellowship (BGF1)
- License Information
-
More Information
Article History
Received: 19 March 2025
Accepted: 19 June 2025
First Online: 3 July 2025
Declarations
:
: All animal experiments were approved by Rhode Island Hospital’s Institutional Animal Care and Use Committee and conformed to the relevant regulatory standards as overseen by the Institutional Animal Care and Use Committee (IACUC). Primary human glioblastoma cells were obtained following surgical removal from patient brain tumors at the Rhode Island Hospital under Institutional Review Board IRB #418015.
